Fellows National Video Conference Series Articles October 2015

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

P. van Hagen, M.C.C.M. Hulshof, J.J.B. van Lanschot, E.W. Steyerberg,  M.I. van Berge Henegouwen, B.P.L. Wijnhoven, D.J. Richel, G.A.P. Nieuwenhuijzen, G.A.P. Hospers, J.J. Bonenkamp, M.A. Cuesta,  R.J.B. Blaisse, O.R.C. Busch, F.J.W. ten Kate, G.-J. Creemers, C.J.A. Punt, J.T.M. Plukker, H.M.W. Verheul, E.J. Spillenaar Bilgen, H. van Dekken,  M.J.C. van der Sangen, T. Rozema, K. Biermann, J.C. Beukema, A.H.M. Piet, C.M. van Rij, J.G. Reinders, H.W. Tilanus, and A. van der Gaast, for the CROSS Group*

Download the PDF



HER 2 Expression in Gastric and Gastro-esophageal Junction (GEJ) Adenocarcinomas

Indu Rajagopali 1, S R Niveditha2, R Sahadev3, Preethan Kamagere Nagappa4, Sowmya Goddanakoppal Rajendra5

Download the PDF



Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung-Jue Bang,* Eric Van Cutsem,* Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh, Giuseppe Aprile, Evgeny Kulikov, Julie Hill, Miachaela Lehl, Josef Rüschoff, Yoon-Koo Kang, for the ToGA Trial Investigators †

Download the PDF



Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials

F. Coccolini a,b,*, E. Cotte b, O. Glehen b, M. Lotti a, E. Poiasina a, F. Catena c, Y. Yonemura d, L. Ansaloni a

Download the PDF



Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

Xiao-Jun Yang, MD1, Chao-Qun Huang, MD1, Tao Suo, MD2, Lie-Jun Mei, MD1, Guo-Liang Yang, MD1, Fu-Lin Cheng, MD1, Yun-Feng Zhou, MD, PhD1, Bin Xiong, MD, PhD1, Yutaka Yonemura, MD, PhD3, and Yan Li, MD, PhD1

Download the PDF



Molecular Imaging of Proliferation and Glucose Utilization: Utility for Monitoring Response and Prognosis after Neoadjuvant Therapy in Locally Advanced Gastric Cancer

Katja Ott, MD1, Ken Herrmann, MD2, Tibor Schuster, PhD3, Rupert Langer, MD4, Karen Becker, MD4, Hinrich A. Wieder, MD5, Hans-Ju¨rgen Wester, PhD2, Jo¨rg-Ru¨diger Siewert, MD6, Christian Meyer zum Bu¨schenfelde, MD7, Andreas K. Buck, MD2, Dirk Wilhelm, MD8, Matthias P. A. Ebert, MD9,10, Christian Peschel, MD7, Markus Schwaiger, MD2, Florian Lordick, MD11, and Bernd Joachim Krause, MD2

Download the PDF



Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study

Guillaume Luc, MD1,2, Caroline Gronnier, MD, PhD3, Gil Lebreton, MD4, Cecile Brigand, MD, PhD5, Jean-Yves Mabrut, MD, PhD6, Jean-Pierre Bail, MD7, Bernard Meunier, MD8, Denis Collet, MD, PhD1, and Christophe Mariette, MD, PhD3

Download the PDF



Molecular Marker Expression Is Highly Heterogeneous in Esophageal Adenocarcinoma and Does Not Predict a Response to Neoadjuvant Therapy

Nathan W. Bronson1 & Brian S. Diggs1 & Gene Bakis2 & Kenneth M. Gatter3 &
Brett C. Sheppard1 & John G. Hunter1 & James P. Dolan1

Download the PDF



Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?

Sheraz Markar, Caroline Gronnier, Alain Duhamel, Arnaud Pasquer, Jérémie Théreaux, Mael Chalret du Rieu, Jérémie H. Lefevre, Kathleen Turner, Guillaume Luc, and Christophe Mariette

Download the PDF